MiRXES is a Singaporean biotech company that’s listed on the Hong Kong stock exchange. Today Elaine Boey will be sitting down with co-founder and CEO, Dr. Zhou Lihan to talk about the technology that the company employs, challenges as Southeast Asia’s biotech unicorn, when it might turn profitable, and whether you should be a shareholder.

Image Credit: Shutterstock.com